Cynthia Patton - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Senior Vice President Chief Compliance Officer

Ms. Cynthia M. Patton is the Senior Vice President, Chief Compliance Officer of Amgen Inc
Age: 54  President Since 2012      
805 447-1010  www.amgen.com
Patton joined the Company in 2005. From July 2005 to September 2010, Ms. Patton was Associate General Counsel. From September 2010 to October 2012, Ms. Patton was Vice President, Law. Previously, Ms. Patton served as Senior Vice President, General Counsel and Secretary of SCAN Health Plan from 1999 to 2005.

Cynthia Patton Latest Insider Activity

Cynthia Patton over six months ago via Macroaxis 
Amgen exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Shannon HallBio Rad Laboratories Inc
2014
Philippe SchaisonAllergan plc
2015
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Robert FordAbbott Laboratories
2015
Murthy SimhambhatlaAbbott Laboratories
2013
Charles FoltzAbbott Laboratories
2013
Robert FunckAbbott Laboratories
2013
Daniel SalvadoriAbbott Laboratories
2014
Thomas FrinziAbbott Laboratories
2016
Michael WarmuthAbbott Laboratories
2012
Deepak NathAbbott Laboratories
2015
JeanYves PaveeAbbott Laboratories
2015
Antonio PeraEndo International plc
2016
Jonathon KellermanAllergan plc
2014
William MeuryAllergan plc
2016
Blaise ColemanEndo International plc
2016
Camille FarhatEndo International plc
2012
Matthew MalettaEndo International plc
2015
Michael CrowleyBio Rad Laboratories Inc
2014
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Paul NavarreAllergan plc

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Pattern Recognition Now
   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
Hide  View All  NextLaunch Pattern Recognition
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators